Correlation of systemic lupus erythematosus clinical phenotypes with anti-double-stranded DNA antibodies and performance comparison of 4 commercial determination kits

Rui SONG,Ping YE,Chaohui WEI,Xiaoxiang CHEN,Jiucun WANG

DOI: https://doi.org/10.3969/j.issn.1673-8640.2017.04.016

IF: 1.865

2017-01-01

Laboratory Medicine

Abstract:Objective To compare the performance of 4 commercial determination kits for anti-double-stranded DNA (dsDNA)antibodies,to analyze the correlation of 15 typical systemic lupus erythematosus (SLE)clinical phenotypes with anti-dsDNA antibodies,and to provide a reference for the diagnosis and monitoring of SLE. Methods A total of 229 SLE patients were enrolled,and 112 patients with other connective tissue diseases were enrolled. Their serum samples were collected. There were 10 typical SLE clinical phenotypes and 5 parameters. All SLE patients were evaluated according to SLE disease activity index (SLEDAI). The levels of anti-dsDNA antibodies were determined by 4 commercial determination kits [kit A using indirect immunofluorescence assay(IFA),kit B and kit C using enzyme-linked immunosorbent assay(ELISA)and kit D using radioimmunoassay]. The performance of the 4 commercial determination kits was evaluated. The correlation of typical SLE clinical phenotypes and parameters with anti-dsDNA antibodies was analyzed. Results The results of 4 commercial determination kits had statisticalsignificance(P<0.01). Kit C had the highest Youden's index,its Youden's index was higher than those of kit B and kit D,and that of kit A was the lowest. The results of kit B,C and D had correlations with SLEDAI (r= 0.482, 0.512 and 0.685,P<0.01). For 10 typical SLE clinical phenotypes and 5 parameters,anti-dsDNA antibodies were correlated positively with increasing anti-nucleosome antibody and decreasing complement (P<0.01). The results of positive anti-nuclear antibodies (P<0.05),nephropathy (P<0.05),leukopenia (P<0.05) and malar rash(P<0.05) in 2 kits were positively correlated with anti-dsDNA antibodies. The other 8 typical SLE clinical phenotypes,including thrombocytopenia and peripheral arthritis,showed no correlation with anti-dsDNA antibodies. Conclusions The performance of 4 commercial determination kits is different. Kit C is adapted to screen SLE,and kit D is suitable for monitoring the activity of SLE. Nephropathy,malar rash,anti-nucleosome antibody, anti-nuclear antibody,decreasing complement and leukopenia are correlated with anti-dsDNA antibodies.